Abstract
Aplastic anemia is a rare disease in children that is most commonly idiopathic and less often a hereditary disorder. Hereditary bone marrow failure (BMF) syndromes, however, should be considered both in children and in adults before any attempt at treatment. Precise diagnosis is important because it will modify prognostic treatment options and the results of bone marrow transplantation. In this review, we will report recent results of treatment of Fanconi anemia and other hereditary BMF syndromes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shimamura A . Inherited bone marrow failure syndrome: molecular features. Hematol Am Soc Hematol Educ Program 2006; 65–71.
Taniguchi T, D'Andrea AD . Molecular pathogenesis of Fanconi anemia: recent progress. Blood 2006; 107: 4223–4233.
Guardiola P, Socie G, Li X, Ribaud P, Devergie A, Esperou H et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 2004; 103: 73–77.
Socie G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998; 103: 249–255.
Rosenberg PS, Greene MH, Alter BP . Cancer incidence in persons with Fanconi anemia. Blood 2003; 101: 822–826.
Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A et al. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386–392.
Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML . Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006; 46: 630–636.
Guardiola P, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh JC et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95: 422–429.
Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256–2262.
Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073–1082.
Grewal SS, Kahn JP, MacMillan ML, Ramsay NK, Wagner JE . Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 2004; 103: 1147–1151.
Rocha V, Devergie A, Socie G, Ribaud P, Esperou H, Parquet N et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 1998; 103: 243–248.
Dror Y, Freedman MH . Shwachman-Diamond syndrome. Br J Haematol 2002; 118: 701–713.
Roy V, Perez WS, Eapen M, Marsh JC, Pasquini M, Pasquini R et al. Bone marrow transplantation for Diamond–Blackfan anemia. Biol Blood Marrow Transplant 2005; 11: 600–608.
Zeidler C, Welte K, Barak Y, Barriga F, Bolyard AA, Boxer L et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95: 1195–1198.
New HV, Cale CM, Tischkowitz M, Jones A, Telfer P, Veys P et al. Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer 2005; 44: 494–499.
Gruhn B, Seidel J, Zintl F, Varon R, Tonnies H, Neitzel H et al. Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. Orphanet J Rare Dis 2007; 2: 5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gluckman, E., Wagner, J. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant 41, 127–132 (2008). https://doi.org/10.1038/sj.bmt.1705960
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705960
Keywords
This article is cited by
-
Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization
Leukemia (2019)
-
Genetic Counseling for Fanconi Anemia: Crosslinking Disciplines
Journal of Genetic Counseling (2014)
-
Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia
Bone Marrow Transplantation (2013)
-
Cord blood transplantation in aplastic anemia
Bone Marrow Transplantation (2013)
-
Current and emerging therapeutic strategies for Fanconi anemia
The HUGO Journal (2012)